Natlimus 0.25mg Tablet: Effective Medication for Your Health

Natlimus 0.25mg Tablet

Uses:

• Advanced breast cancer
• Advanced renal cell carcinoma
• Advanced pancreatic neuroendocrine tumours
• Treatment of subependymal giant cell astrocytoma

Therapeutic Effects:

• Inhibits the activity of mammalian target of rapamycin (mTOR), which regulates cell growth
• Slows the growth of abnormal cancer cells
• Helps to reduce the size of tumours and improve outcomes in patients

Dosage and Administration:

• Take as advised by your physician
• Do not crush, chew, or open the medicine
• Dosage and duration depend on age, body weight, and disease condition

Safety Advice:

• Not recommended for pregnant women as it may cause fetal harm
• Unsafe to breastfeed while taking this tablet
• Consult your doctor if you have any lung or liver diseases
• Avoid alcohol consumption
• Do not drive vehicles or operate heavy machinery after taking the tablet, as it may cause dizziness and impair concentration

Interaction with Other Drugs:

• Inform your healthcare provider about all the medicines you take
• Certain medications may interact with Natlimus 0.25mg tablet and reduce effectiveness by causing undesirable side effects

Side Effects:

• Difficulty breathing or swallowing
• Swelling of face, lips, tongue, throat
• Severe itching, red rash, raised bumps
• Infection (chills, increased temperature)
• Coughing
• Wheezing
• Excessive thirst
• High urine output or severely decreased urine output
• Tiredness
• Bleeding
• Increased appetite with weight loss

Storage:

• Store at room temperature (20°C to 25°C)
• Keep out of reach from children

FAQ:

1. What you should know before taking Natlimus 0.25mg tablet? Before taking Natlimus 0.25mg tablet, it is important to know that your risk of getting bacterial or viral infection increases with this treatment. If you have been infected with Hepatitis B, this drug increases the chances of reinfection. Tell your healthcare provider if you experience fever, chills, cough, yellowing of the skin, joint pain, or swelling during this treatment.

2. Is it safe to use Natlimus 0.25mg tablet during pregnancy? Natlimus 0.25mg tablet has the tendency to cause harm to the unborn fetus. Inform your healthcare provider before starting this treatment if you are pregnant, or planning for pregnancy. Your healthcare provider will conduct a pregnancy test before you start treatment with this drug.

3. What are the side effects of Natlimus 0.25mg Tablet? The common side effects that are likely to occur while you are on the treatment with Natlimus 0.25mg tablet are fever, chills, skin rash, joint pain, swelling, tiredness, loss of appetite, high risk of infection, mouth ulcers, and difficulty breathing.

4. Is it safe to undergo surgery while on treatment with Natlimus 0.25mg tablet? Natlimus 0.25mg tablet may lead to poor wound healing ability. Consult your healthcare provider and stop taking this tablet at least one week before planned surgery.

5. Can I drink alcohol while taking Natlimus 0.25mg tablet? It is generally recommended to avoid drinking alcohol while taking Natlimus 0.25mg tablet, as alcohol can increase the risk of liver damage.

Fact Box:

• Molecule name: Everolimus
• Therapeutic class: Antineoplastics
• Pharmacological class: mTOR kinase inhibitors

Tags: natlimus, tablet, 0.25mg, medicine, health, pharmacy